Dow Jones 30 Stocks SEC Filings — May 29, 2026

29-05-2026

AGNC Investment Corp. implemented a new at-the-market (ATM) common stock issuance program on May 28, 2026, allowing it to sell up to $2.0 billion of common stock through multiple agents including Goldman Sachs, Barclays, and Morgan Stanley. The program provides the company with significant capital-raising flexibility, with agents receiving up to 1.0% of gross sales price as compensation. No shares have been sold yet under this program, and there are no negative or flat performance metrics to report as this is a forward-looking capital markets action.

• · The ATM program is authorized under the company's existing automatic shelf registration statement on Form S-3ASR (File No. 333-279249) filed May 9, 2024.
• · Sales may be conducted through ordinary brokers' transactions, market maker transactions, on Nasdaq, over-the-counter, or in privately negotiated transactions including block trades.
• · The program terminates upon the earlier of sale of all $2B in shares or termination of the sales agreements by either party.
• · Skadden, Arps, Slate, Meagher & Flom LLP provided a legal opinion on the offering, filed as Exhibit 5.1.

29-05-2026

Community West Bancshares held its Annual Meeting on May 27, 2026, with 72.23% of outstanding shares represented. All 13 director nominees were elected, and shareholders ratified the appointment of Baker Tilly LLP as independent auditor with overwhelming support (99.9% of votes cast). However, the non-binding advisory resolution on executive compensation received notable opposition, with 876,079 votes against (5.4% of votes cast) and 60,855 abstentions, indicating some shareholder dissent on pay practices.

• · Daniel J. Doyle received the lowest support among director nominees with 12,913,074 votes for and 3,292,881 votes withheld (20.3% withheld).
• · Kirk B. Stovesand also had significant withheld votes: 123,883 against 13,053,991 for (0.9% withheld).
• · All director elections had 3,372,885 broker non-votes, representing about 17.2% of shares represented.
• · The advisory compensation resolution had 15,269,021 votes for, 876,079 against, and 60,855 abstentions, plus 3,372,885 broker non-votes.
• · The auditor ratification had no broker non-votes, with 19,556,109 for, 12,393 against, and 10,338 abstentions.

29-05-2026

Calavo Growers, Inc. completed its acquisition by Mission Produce, Inc. on May 28, 2026, through a two-step merger process. Calavo shareholders received 0.9790 Mission Produce shares and $14.85 in cash per Calavo share, with total consideration of approximately 17.5 million Mission Produce shares and $265.9 million in cash. All Calavo directors resigned effective at closing, and Calavo common stock was delisted from Nasdaq.

• · The Merger Agreement was originally dated January 14, 2026.
• · Calavo's credit agreement with Wells Fargo Bank was repaid and terminated upon closing.
• · All outstanding Calavo stock options, RSUs, and deferred RSUs were cancelled and converted into cash based on the Merger Consideration Value of $27.69.
• · Calavo common stock was delisted from Nasdaq on May 28, 2026, and the company intends to file Form 15 to suspend SEC reporting obligations.
• · The surviving entity after the mergers is Calavo Growers, LLC, a Delaware limited liability company.

29-05-2026

On May 28, 2026, Heritage Insurance Holdings, Inc. announced it has fully placed its 2026-2027 indemnity-based catastrophe excess-of-loss reinsurance program for its three insurance subsidiaries. The 8-K filing simply reports this event via a press release; no financial results, performance metrics, or period-over-period comparisons are provided.

• · The reinsurance program covers the 2026-2027 treaty year.
• · The program is catastrophe excess-of-loss and indemnity-based.
• · Subsidiaries covered: Heritage Property Casualty Insurance Company, Narragansett Bay Insurance Company, and Zephyr Insurance Company.
• · No attachment point, limit, or cost details are disclosed in the filing.

29-05-2026

Rani Therapeutics Holdings, Inc. held its 2026 Annual Meeting on May 28, 2026, where all director nominees were elected and the ratification of CBIZ CPAs P.C. as independent auditor for FY2026 was approved. The company reported 99,812,515 Class A and 23,970,359 Class B shares outstanding, with all shares voting as a single class. All seven director nominees received strong support, though Jean-Luc Butel drew a notable 4,997,042 votes withheld (about 8.7% of votes cast), while the auditor ratification passed with 77,019,828 votes in favor against only 332,645 against.

• · Record date for the Annual Meeting was April 2, 2026, with total voting shares of 123,782,874 (99,812,515 Class A + 23,970,359 Class B).
• · All seven director nominees were elected to serve until the 2027 annual meeting.
• · Broker non-votes totaled 19,921,604 on each director election, indicating significant shares held by brokers that did not vote on the director elections.
• · Jean-Luc Butel had the highest number of votes withheld (4,997,042), representing approximately 8.7% of votes cast on that proposal (excluding broker non-votes), notably higher than the other six directors whose withheld votes ranged from 0.18% to 1.55%.
• · Ratification of CBIZ CPAs P.C. passed with 77,019,828 votes in favor, 332,645 against, and 54,190 abstentions — a 99.5% approval rate of votes cast.
• · The Definitive Proxy Statement was filed on April 16, 2026.

29-05-2026

Quest Water Global, Inc. engaged KAN Accounting Solutions pllc as its new independent accountant on May 27, 2026, replacing Fruci & Associates II, PLLC, which resigned at the company's request on May 5, 2026. The board of directors approved the change. No consultations occurred with KAN regarding accounting principles, audit opinions, disagreements, or reportable events during the fiscal years ended December 31, 2025 and 2024, and through May 27, 2026.

• · Fruci & Associates II, PLLC resigned as independent accountant on May 5, 2026, at the company's request.
• · The company's fiscal years ended December 31, 2025 and 2024, and the period through May 27, 2026, had no consultations with KAN regarding accounting principles, audit opinions, disagreements, or reportable events.
• · Details of Fruci's resignation are referenced in a separate Form 8-K dated May 6, 2026.

29-05-2026

Hallmark Venture Group, Inc. reported a net loss of $273,496 for the three months ended March 31, 2026, an improvement from a net loss of $728,927 in the same period of 2025. The company had no revenue in either period, while total operating expenses decreased to $38,571 from $58,010. However, the company's cash position declined to $1,946 from $3,382 at year-end 2025, and it continues to operate with a stockholders' deficit of $174,690.

• · The company had no revenue in either Q1 2026 or Q1 2025.
• · Net loss from discontinued operations was $0 in Q1 2026 versus $426,960 in Q1 2025.
• · Weighted average shares outstanding increased dramatically from 1,047,852 in Q1 2025 to 65,610,811 in Q1 2026.
• · Net loss per share improved from $(0.70) to $(0.01).
• · Total assets decreased from $3,382 to $1,946.
• · Accounts payable and accrued liabilities decreased from $191,266 to $171,556.
• · Convertible notes payable (net of discount) decreased from $52,840 to $496.
• · Accrued interest was $0 at March 31, 2026, down from $2,350 at December 31, 2025.
• · Additional paid-in capital increased from $4,820,895 to $5,313,003 due to stock issued for debt conversion.
• · Net cash used in operating activities was $59,077 in Q1 2026, compared to $17,085 used in Q1 2025.
• · Proceeds from convertible note payable were $57,641 in Q1 2026.
• · Non-cash transactions included $132,341 of common stock issued for debt and $27,346 for related party debt.
• · Warrants outstanding remained at 12 with a weighted average exercise price of $500 and intrinsic value of $0.

29-05-2026

FTAI Aviation Ltd. held its 2026 Annual General Meeting on May 28, 2026, where shareholders elected three Class I directors (Joseph P. Adams, Jr., Judith A. Hannaway, and Martin Tuchman), approved on a non-binding advisory basis the compensation of named executive officers, and ratified the appointment of KPMG LLP as independent auditor for fiscal year 2026. All proposals passed with strong shareholder support, though Judith A. Hannaway received a notable 15.9% withhold vote (13,558,827 votes withheld out of 85,411,343 votes cast).

• · Judith A. Hannaway received 13,558,827 votes withheld, representing 15.9% of votes cast, significantly higher than the other two director nominees.
• · Broker non-votes totaled 8,894,304 shares for both director elections and the advisory say-on-pay vote.
• · The ratification of KPMG as auditor passed with 94,181,439 votes for, only 101,827 against, and 22,381 abstentions.
• · The advisory say-on-pay proposal received 80,859,607 votes for, 4,510,523 against, and 41,213 abstentions.

29-05-2026

Bandwidth Inc. (BAND) held its 2026 Annual Meeting on May 28, 2026, with 87.08% of eligible votes represented. Stockholders elected David A. Morken and Rebecca G. Bottorff as Class III directors, ratified Ernst & Young LLP as auditors with overwhelming support (99.6% 'For'), and approved say-on-pay and say-on-frequency proposals. However, director elections showed notable opposition, with 18.1% withheld for Morken and 22.2% for Bottorff, and say-on-pay received 24.5% 'Against' votes, indicating significant shareholder dissent on compensation and board composition.

• · The company will hold future advisory votes on executive compensation annually until at least the 2032 annual meeting.
• · Record date for voting was April 1, 2026.
• · Class B common stockholders had 10 votes per share; Class A had 1 vote per share.
• · Proposal 3 (say-on-pay) passed with 30,884,728 For vs 10,011,929 Against (74.1% approval, excluding abstentions).
• · Proposal 4 (say-on-frequency) received a 3-year interval preference as the least popular choice (1,526,775 votes), while 'Every Year' had dominant support.
• · Auditor ratification passed with 43,322,421 For (99.6% of votes cast).

29-05-2026

KLA-iBotics Holdings Ltd, a BVI holding company with operations in Hong Kong, filed an F-1 registration statement for an initial public offering of 6,250,000 Class A ordinary shares at an expected price range of $4.00 to $6.00 per share, with plans to list on NYSE American. The company is a controlled company, with Kamui Development Group Limited (a subsidiary of Reitar Logtech, listed on Nasdaq) holding 100% of Class B shares representing approximately 88.09% of total voting power. However, the company faces significant risks, including extreme customer concentration—96.8% and 93.1% of total revenue for the two years ended March 31, 2025 and 2024, respectively, came from one affiliated customer, Kamui Construction & Engineering Group Limited—and that customer generated no revenue for the six months ended September 30, 2025 as the relevant project was completed.

• · The company is an emerging growth company as defined under Rule 405 of the Securities Act.
• · The company intends to apply to list on NYSE American under a symbol to be determined.
• · Each Class A ordinary share is entitled to one vote; each Class B ordinary share is entitled to twenty votes and is convertible into one Class A share.
• · The company is a BVI holding company with no material operations of its own; operations are conducted through Hong Kong subsidiaries.
• · The company does not have a VIE structure and does not intend to establish one.
• · The auditor, Enrome LLP, is located in Singapore and is inspected by the PCAOB on a regular basis.
• · The company is subject to risks under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect its auditor for two consecutive years.
• · The company may face restrictions on cross-border transfers of cash or assets from Hong Kong subsidiaries due to PRC government interventions.

29-05-2026

VERAXA Biotech strengthened its financial position for its business combination with Voyager Acquisition Corp. by securing a $27.5M senior secured note from an institutional investor and entering into a $50M at-the-market share purchase agreement with Lincoln Park Capital. The transactions provide flexible capital to advance its pipeline of BiTAC-TCE and BiTAC-ADC cancer therapies toward clinical development and initial value inflection points.

• · The Note is a senior secured obligation of VERAXA, secured by all VERAXA assets and ranking senior to all unsecured indebtedness.
• · Any amortization payment under the Note may be made in cash, in registered-for-resale shares of common stock, or a combination thereof, at VERAXA's sole option.
• · The holder of the Note has the right to require VERAXA to redeem up to 20% of the gross proceeds of any future equity or equity-linked financing (cash sweep).
• · VERAXA may redeem the Note at par at any time without penalty, subject to certain conditions.
• · The SPA with LPC contains no warrants, rights of first refusal, or participation rights, and LPC agreed not to engage in any short selling or hedging of VERAXA common stock.
• · The business combination agreement with Voyager was entered into on April 22, 2025, and a proxy statement/prospectus was filed with the SEC on February 19, 2026.

29-05-2026

Treasure Global Inc (TGL) entered into a Subscription Agreement with Legacy Trustee Berhad on May 26, 2026, for a private placement of $1.2M in common stock, structured as four equal tranches of $300,000 each due by June 23, 2026. The shares are priced at the greater of $3.88 per share or the closing price prior to each tranche's completion date, and the company must file a resale registration statement within 60 days. The agreement is governed by Malaysian law and includes binding, irrevocable commitments from the investor with no financing contingencies.

• · The shares are 'restricted securities' under the Securities Act and subject to Rule 144 resale limitations.
• · The company must use commercially reasonable efforts to maintain the registration statement's effectiveness for up to two years or until all shares are sold or can be sold under Rule 144 without limitations.
• · Each party has agreed to indemnify the other for losses arising from breaches of warranties or misrepresentations.
• · If the investor fails to pay, the company can terminate the agreement and cancel all issued shares; if the company fails to transfer shares, the investor can terminate.
• · The agreement is governed by Malaysian law with jurisdiction in Malaysian courts.

29-05-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) announced that its subsidiary NCL Corporation Ltd. has irrevocably elected to settle all exchanges of its 1.125% and 2.50% Exchangeable Senior Notes due 2027 in cash, effective May 29, 2026. This election is expected to reduce diluted weighted-average shares outstanding guidance by approximately 2 million shares for Q2 2026 and 4 million shares for full-year 2026, which should mitigate dilution for existing shareholders.

• · The election applies to all exchanges with an Exchange Date on or after May 29, 2026.
• · The 1.125% Notes were issued under an indenture dated November 19, 2021; the 2.50% Notes under an indenture dated February 15, 2022.
• · The election is irrevocable and was made by delivering notice to holders and the trustee.

29-05-2026

Fathom Holdings Inc. (FTHM) received a Nasdaq notification on May 22, 2026, for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The company has 60 days (until July 21, 2026) to submit a compliance plan, and if accepted, Nasdaq may grant an exception until November 11, 2026. While the notice has no immediate effect on trading, failure to regain compliance could lead to delisting, and the company has not yet filed the Form 10-Q, indicating ongoing reporting delays.

• · The notification letter was received on May 22, 2026, and the 8-K was filed on May 29, 2026.
• · The company's common stock continues to trade on the Nasdaq Capital Market under symbol FTHM with no immediate impact on listing.
• · If Nasdaq rejects the compliance plan, the company can appeal to a Nasdaq hearings panel under Listing Rule 5815(a).
• · Any subsequent periodic filing due within the exception period must also be filed by the end of that period.

29-05-2026

Enveric Biosciences held its 2026 Annual Meeting on May 28, 2026, with 52.54% of outstanding shares represented. Stockholders approved the election of six directors, the Say-on-Pay proposal, a reverse stock split (1-for-5 to 1-for-15), and auditor ratification. However, the proposal to increase authorized common stock from 100,000,000 to 5,000,000,000 shares was voted down, with 555,147 votes against versus 427,158 for. The Board also adopted new forms of RSU and RSA agreements under the 2020 Long-Term Incentive Plan for future grants to executives and directors.

• · The Authorized Stock Increase Proposal was rejected: 427,158 for, 555,147 against, 9,523 abstentions.
• · The Reverse Stock Split Proposal passed with 793,344 for, 190,175 against, 8,309 abstentions.
• · The Say-on-Pay Proposal passed with 569,552 for, 26,884 against, 5,297 abstentions.
• · Auditor Ratification passed overwhelmingly: 960,728 for, 19,347 against, 11,753 abstentions.
• · All six director nominees were elected; broker non-votes were 390,095 for each nominee.
• · The new RSU Agreement provides for 4-year time-based vesting (25% on first anniversary, then monthly installments) and full acceleration upon change in control.
• · The new RSA Agreement provides for time-based vesting on a specified date with forfeiture of unvested shares upon termination.

29-05-2026

Viasat Inc. filed its 10-K annual report for the fiscal year ended March 31, 2026. Total revenues grew 3% YoY to $4.64B, with service revenues up 2% and product revenues up 6%. However, the company reported a net loss of 1% of revenues (approx. -$46M), an improvement from a 13% net loss in FY25. Segment operating profit was essentially flat at $216.3M vs $216.7M, with margin declining from 18% to 16%.

• · Cash and cash equivalents increased to $1.75B as of March 31, 2026 from $1.61B at March 31, 2025
• · Total assets decreased slightly to $15.23B from $15.45B
• · Total liabilities decreased to $10.50B from $10.80B
• · Accumulated deficit worsened to $359.6M from $325.6M (calculated)
• · Selling, general and administrative expenses declined from 26% of revenue to 22%
• · Interest expense net improved from 7% of revenue to 3%
• · Income from continuing operations before taxes improved from a loss of 12% to a gain of 2% of revenue
• · Expected amortization for FY2027 is $263.3M, declining gradually over the next five years
• · Total contractual obligations of $1.68B due within 12 months and $9.82B thereafter
• · Acquired intangible assets net decreased to $2.00B from $2.27B due to amortization

29-05-2026

Invesco Commercial Real Estate Finance Trust, Inc. declared monthly distributions of $0.1600 per share for all seven classes of common stock for May 2026, payable on June 12, 2026 to stockholders of record as of May 31, 2026. Net distributions range from $0.1420 (Class S-1 after servicing fee) to $0.1600 (Classes D, I, E, F with no servicing fee). The gross distribution amount is uniform across all classes, with no period-over-period comparison provided in this filing.

• · Each class receives the same gross distribution of $0.1600 per share, but net amounts differ due to stockholder servicing fees.
• · Class S-1 has the lowest net distribution at $0.1420 per share due to the highest servicing fee of $0.0180.
• · Classes D, I, E, and F have no servicing fee, resulting in a full net distribution of $0.1600 per share.
• · Distributions are payable in cash or reinvested in shares for participants in the distribution reinvestment plan.
• · The record date is May 31, 2026 (5:00 PM Eastern time) and payment date is on or about June 12, 2026.

29-05-2026

Maravai LifeSciences Holdings, Inc. held its 2026 Annual Meeting on May 26, 2026, with a quorum of 236,082,968 shares present. Shareholders elected three directors (Bernd Brust, Gregory T. Lucier, Luke Marker) to three-year terms, ratified Deloitte & Touche LLP as independent auditor for fiscal year 2026, and approved non-binding advisory say-on-pay compensation. All proposals passed with majority support, though Proposal 1 director elections saw approximately 9-11% of votes withheld against each nominee, indicating modest but notable dissent.

• · Shareholders ratified Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026 with 234,492,897 votes for, 1,246,939 against, 343,132 abstentions
• · Non-binding advisory say-on-pay proposal received 200,054,156.49 votes for, 312,439 abstentions, and 33,258,969.51 broker non-votes
• · Director Bernd Brust received 182,998,545 votes for and 19,825,453.49 withheld (9.8% withheld), Gregory T. Lucier received 179,514,826 for and 23,309,172.49 withheld (11.5% withheld), Luke Marker received 182,239,834 for and 20,584,164.49 withheld (10.2% withheld)
• · Record date for the annual meeting was March 27, 2026
• · Company has dual-class share structure with Class A and Class B common stock

29-05-2026

On May 29, 2026 Spire Global, Inc. (SPIR) announced that Chief Operating Officer Celia Pelaz informed the company she will resign effective September 30, 2026 to pursue a role with another organization. The company does not intend to replace the COO role and has initiated a search for a Chief Commercial Officer consistent with its 2026 strategic priorities; the filing states the resignation was not due to any disagreement about operations, policies, practices, financial reporting or controls.

• · Resignation notice date: May 29, 2026
• · Effective resignation date: September 30, 2026
• · Company telephone: (202) 301-5127
• · Registrant address: 8000 Towers Crescent Drive, Suite 1100, Vienna, Virginia 22182
• · Company will initiate search for a Chief Commercial Officer and does not currently intend to replace the COO role

29-05-2026

Kentucky First Federal Bancorp (KFFB) announced that its Board of Directors will hold a special meeting on July 28, 2026 to consider resuming a quarterly dividend of up to $0.10 per share, after suspending dividends since November 2023. However, the Board may declare a lower dividend or none at all, and no final decision has been made. The dividend resumption is contingent on First Federal MHC (holding 58.5% of shares) waiving its right to receive dividends aggregating up to $0.40 per share over 12 months, and on non-objection from the Federal Reserve Bank of Cleveland.

• · Dividends were suspended on January 16, 2024, and no dividend has been paid since November 2023.
• · First Federal MHC previously approved similar dividend waiver proposals from 2012 through 2023.
• · The special Board meeting on July 28, 2026 will follow the First Federal MHC member meeting to vote on the waiver proposal.
• · Any dividend declaration remains subject to non-objection from the Federal Reserve Bank of Cleveland.

29-05-2026

Bain Capital Private Credit declared a regular distribution of $0.1875 per share for Class I shares, payable on June 30, 2026. As of April 30, 2026, the fund reported an aggregate NAV of $1,039.0 million and a NAV per share of $25.87, with a debt-to-equity ratio of 1.20x. The investment portfolio was valued at $2,076.9 million across 171 companies, with 88% in first lien senior secured debt and 93% of debt investments at floating rates.

• · The distribution of $0.1875 per share will be paid in cash or reinvested under the distribution reinvestment plan.
• · Net debt-to-equity ratio (excluding cash and unsettled trades) was approximately 0.99x as of April 30, 2026.
• · Portfolio composition includes 1% second lien senior secured debt, 5% subordinated debt, 2% preferred equity, 2% common equity, and 2% in an investment vehicle.
• · Total shares issued and outstanding as of May 1, 2026: 40,938,335 Class I shares.

29-05-2026

Faraday Future Intelligent Electric Inc. (FFAI) announced a strategic partnership with Sequoia Education Center, a leading K-12 education group in North America, and signed a sales contract for 23 FF EAI robots, its largest robot order to date. The company also delivered a Master humanoid robot to a medical institution in Los Angeles, marking its first healthcare use case. At the annual stockholders' meeting on May 22, 2026, all proposals received roughly 80% approval support. However, the filing also highlights ongoing risks including the company's ability to continue as a going concern, lack of sufficient share capital, and potential Nasdaq delisting if the stock price falls to $0.10 or less for 10 consecutive trading days.

• · The company has delivered a Master humanoid robot to a medical institution in Los Angeles, its first healthcare use case.
• · FF's collaboration with RobotShop is progressing smoothly, and several major North American e-commerce platforms have expressed interest in partnering on robotics sales.
• · The EAI Brain and Skills ecosystem has developed dozens of Skills covering education, security, reception, guided tours, and companion services.
• · The developer platform includes six major tools; two (BrainBlocks and EAI Soul) are already completed, with the remaining tools rolling out later in May 2026.
• · Decentralized real-world robot data collection is expected to be completed in June 2026.
• · The company faces risks including potential Nasdaq delisting if the stock price falls to $0.10 or less for 10 consecutive trading days, and the need for substantial additional funding to execute its FX strategy.

29-05-2026

Walmart reported strong Q1 FY27 results with total revenues increasing 7.3% YoY to $177.8B and net income attributable to Walmart rising 18.8% to $5.33B. However, comprehensive income attributable to Walmart fell 6.3% to $4.50B due to a sizable other comprehensive loss, while operating cash flow declined 12.4% to $4.74B as inventory investments and lower accrued liabilities offset higher net income.

• · Other comprehensive loss attributable to Walmart was $835M in Q1 FY27 vs. a gain of $309M in Q1 FY26, driving the decline in comprehensive income.
• · The company paid $1.97B in dividends and repurchased $2.08B of stock during Q1 FY27.
• · Capital expenditures rose 34.1% YoY to $6.68B.
• · Total debt (long-term debt due within one year + long-term debt) increased to $40.78B from $38.17B at fiscal year-end.
• · Net cash provided by financing activities was $2.33B in Q1 FY27 vs. only $8M in Q1 FY26, driven by higher short-term borrowing and long-term debt issuance.

29-05-2026

Olaplex Holdings, Inc. announced on May 29, 2026 that the U.S. District Court for the Central District of California granted preliminary approval of a settlement in the stockholder derivative litigation. The settlement requires the company to implement certain governance enhancements and pay plaintiffs' counsel's attorneys' fees and expenses, subject to final court approval.

• · Settlement resolves all claims that were or could have been asserted in the derivative litigation and the § 220 books and records demand by stockholder Kajeel Patel.
• · The settlement is subject to final court approval; a settlement hearing date has not been specified in the filing.

29-05-2026

Apple Hospitality REIT, Inc. filed an 8-K on May 29, 2026, disclosing an updated investor presentation containing operating statistics for April and May 2026. The presentation is furnished as Exhibit 99.1 and is intended for use at upcoming conferences and meetings. The filing is a Regulation FD disclosure and does not contain detailed financial results or period-over-period comparisons.

• · The investor presentation was made available on the company's website on May 29, 2026.
• · The presentation includes operating statistics for April and May 2026.
• · The filing is furnished under Items 7.01 and 9.01 of Form 8-K and is not deemed filed for Exchange Act purposes.

29-05-2026

DraftKings Inc. announced on May 29, 2026, that CFO Alan Ellingson will also assume the role of principal accounting officer (PAO), effective immediately, with no change in compensation. Erik Bradbury, the previous PAO, will remain as Chief Accounting Officer. The filing contains no financial data or period-over-period comparisons.

• · Alan Ellingson will not receive any additional compensation for the PAO role.
• · Erik Bradbury remains as Chief Accounting Officer despite the change.
• · The change follows a review of executive officer and senior leadership team functions.

29-05-2026

Aveanna Healthcare Holdings Inc. held its 2026 Annual Meeting on May 29, 2026, where stockholders voted on three proposals. All three Class II director nominees (Rodney D. Windley, Sam Weil, and Steven E. Rodgers) were elected, and the appointment of Ernst & Young LLP as independent auditor was ratified with overwhelming support (over 99% of votes cast). However, the non-binding advisory vote on executive compensation received only 89.1% support, with 10.8% of votes cast against, indicating notable shareholder dissent on pay practices.

• · Broker non-votes totaled 19,773,305 shares on director elections and the executive compensation proposal.
• · Director Steven E. Rodgers received the highest support with 168,380,101 votes for (93.7% of votes cast), while Rodney D. Windley received the lowest with 150,079,425 votes for (83.5% of votes cast).
• · The auditor ratification proposal had no broker non-votes, indicating it was considered a routine matter.
• · No other matters were considered or voted upon at the Annual Meeting.

29-05-2026

LyondellBasell Industries N.V. (LYB) entered into the Eighth Amendment to its Receivables Purchase Agreement, effective June 26, 2026, which refinances the facility by paying off MUFG Bank, Ltd. and Gotham Funding Corporation, replacing SMBC Nikko Securities America, Inc. with Sumitomo Mitsui Banking Corporation as Purchaser Agent, and amending the agreement terms. The amendment maintains the existing facility structure with Mizuho Bank, Ltd. as Administrator and LC Bank, and no termination events or defaults were reported.

• · The amendment is effective June 26, 2026, though signed on May 29, 2026.
• · MUFG Bank, Ltd. and Gotham Funding Corporation are being paid off and removed from the agreement.
• · SMBC Nikko Securities America, Inc. assigns its role as Purchaser Agent to Sumitomo Mitsui Banking Corporation.
• · No Termination Event or Unmatured Termination Event exists before or after the amendment.
• · The original Receivables Purchase Agreement was dated September 11, 2012, and this is the eighth amendment.

29-05-2026

Avis Budget Group appointed Tina Goldenberg as Vice President and Chief Accounting Officer, effective June 15, 2026, succeeding Cathleen DeGenova who is retiring. Ms. DeGenova will remain as Senior Vice President and Chief Accounting Officer until June 14, 2026, and will advise the Company through April 1, 2027. Ms. Goldenberg will receive an annual base salary of $270,000 and is eligible for an annual incentive award at a target rate of 45% of base salary.

• · Ms. Goldenberg, age 42, has been a Senior Director overseeing Accounting for the Company’s Americas region since March 2020.
• · She joined the Company in March 2013 and previously held roles in Internal Reporting and Financial Reporting & Technical Accounting.
• · Prior to joining Avis Budget, Ms. Goldenberg was an accountant with Deloitte and is a Certified Public Accountant.
• · Cathleen DeGenova will continue to advise the Company through April 1, 2027, to assist with the orderly transition.

29-05-2026

InvenTrust Properties Corp. filed an 8-K on May 29, 2026, disclosing that it posted an updated investor presentation on its website for use at conferences and meetings. The filing is a routine Regulation FD disclosure and does not contain any financial results or material operational updates.

• · The investor presentation is attached as Exhibit 99.1 to the 8-K.
• · The presentation is effective as of May 29, 2026.
• · The information is furnished, not filed, under the Exchange Act.

29-05-2026

Antares Private Credit Fund declared a regular distribution of $0.1887 per share payable on June 29, 2026, and reported an April 30, 2026 NAV per share of $24.69. The fund's aggregate NAV was $802.8 million with loan commitments of $2,057.7 million, while debt outstanding of $946.3 million resulted in a debt-to-equity ratio of 1.18x and net leverage of 1.12x. The continuous offering has raised $817.0 million from 32.6 million shares issued through May 1, 2026.

• · The distribution of $0.1887 per share is payable to shareholders of record as of May 28, 2026, and will be paid on or about June 29, 2026.
• · The NAV per share for Class I shares as of April 30, 2026, is $24.69.
• · The debt-to-equity (NAV) ratio is 1.18x, and the net leverage ratio is 1.12x.
• · The offering is continuous up to $2.0 billion in shares, with shares sold monthly at a price generally equal to NAV per share.
• · The total consideration from the offering through May 1, 2026, is $817,032,140 from 32,627,717 Class I shares issued.

29-05-2026

Avalanche Treasury Corp and its subsidiary Avalanche Treasury Company, LLC (AVAT) entered into a $25 million collateralized open loan agreement with FalconX Charlie, Inc. on May 29, 2026, to finance closing costs related to their pending business combination with Mountain Lake Acquisition Corp. The loan carries a 7% per annum fee and is secured by approximately 5.6 million AVAX tokens (200% initial collateral ratio). Separately, the registrants released unaudited financial results for the three months ended March 31, 2026, but no specific financial figures or performance trends were disclosed in this filing.

• · The Master Lender Agreement was signed on March 20, 2026, and the loan term sheet was executed on May 29, 2026.
• · The loan is an Open Loan with no fixed maturity date; AVAT may repay and FalconX may recall at any time.
• · Collateral will be held in a segregated custody account with Anchorage Digital Bank N.A.
• · Staking of collateral is limited to 75% and must use a laddered epoch strategy ensuring 50% matures weekly.
• · The loan proceeds will be used to finance closing costs of the business combination.
• · The filing includes unaudited financial statements for both entities for Q1 2026, but no financial results are summarized in this 8-K.

29-05-2026

BullFrog AI Holdings, Inc. filed an S-1 registration statement on May 29, 2026, to register an additional 2,000,000 shares of common stock for resale by Lincoln Park under a Purchase Agreement. The company has a going concern opinion from its auditor, has recently regained compliance with Nasdaq's stockholders' equity requirement after raising $3.45 million, but remains non-compliant with the minimum bid price rule (below $1.00 per share) with a compliance deadline of August 10, 2026. On a positive note, the company entered a feasibility agreement with a global pharmaceutical company in March 2026 to apply its bfLEAP® AI platform for drug target discovery in major depressive disorder.

• · The company received a Nasdaq non-compliance notice on February 10, 2026 for bid price below $1.00; has until August 10, 2026 to regain compliance.
• · Stockholders approved a reverse stock split in October 2025 (ratio 1:2 to 1:15), which the board may use to address bid price deficiency.
• · The feasibility agreement with a global pharma company for MDD drug target discovery runs for one year from March 27, 2026.
• · The company qualifies as an emerging growth company and has elected not to opt out of extended transition period for new accounting standards.
• · The company does not intend to pay dividends on common stock.
• · Lincoln Park's purchase commitment is up to $10 million; the company may not have access to the full amount.
• · The company's auditor included a going concern explanatory paragraph in its report on the December 31, 2025 financial statements.

29-05-2026

PEOPLES BANCORP INC (PEBO) filed an S-4 registration statement on May 29, 2026, in connection with its proposed merger with Citizens, where Citizens shareholders will receive 2.10 Peoples common shares and $8.00 in cash per Citizens share. The filing highlights significant risks, including potential difficulties integrating Citizens' operations, loss of key employees, and the limited market for Citizens' OTC-traded shares, which may affect the fairness assessment. Former Citizens shareholders are expected to own approximately 5.4% of the combined company, reducing their influence, and the merger is subject to a $3 million termination fee if Citizens pursues an alternative acquisition.

• · The Exchange Ratio is fixed at 2.10 Peoples shares per Citizens share, subject to customary anti-dilution adjustments and a potential increase if Peoples' stock price declines relative to the Nasdaq Bank Index.
• · Citizens' common shares trade on the OTC market with limited and sporadic volume, making market price an unreliable indicator of fair value.
• · The fairness opinion from Hovde is dated April 20, 2026, and does not reflect changes after that date.
• · The merger agreement restricts Citizens from soliciting alternative proposals and requires a $3 million termination fee under certain conditions.
• · If the merger fails, Citizens may face negative reactions from customers and employees, and litigation risks.

29-05-2026

Onfolio Holdings Inc. received a Nasdaq notice on May 26, 2026, for non-compliance with the minimum stockholders' equity requirement of $2,500,000, reporting only $1,216,603 in equity as of March 31, 2026. The company also fails alternative listing standards based on market value of listed securities ($35 million) or net income from continuing operations ($500,000). The company has until July 10, 2026, to submit a compliance plan, but there is no assurance of acceptance or ability to regain compliance, posing a material risk of delisting.

• · The company also fails alternative continued listing standards: market value of listed securities of $35 million and net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three years.
• · If the compliance plan is not accepted or compliance is not regained, the company has the right to request a hearing before an independent Nasdaq hearings panel, which would stay any suspension or delisting action pending the hearing process.
• · The notice and non-compliance do not have an immediate effect on the trading of the company's common stock under the symbol 'ONFO'.

29-05-2026

CCC Intelligent Solutions Holdings Inc. filed an 8-K/A to disclose compensation arrangements for Rodney Christo, who was appointed Interim Chief Financial Officer following Brian Herb's resignation. Christo's base salary increases to $425,000 per year for a transition period, and he is eligible for a one-time transition cash bonus between $125,000 and $200,000, contingent on the length of the transition and successful onboarding of a successor CFO. The filing does not include any financial performance data, so no period-over-period comparisons are available.

• · The transition period begins on May 25, 2026 and continues until a successor CFO is appointed and onboarded.
• · The transition bonus is payable in a lump sum on the first payroll date after the earlier of the end of the transition period or December 31, 2026.
• · The transition bonus is forfeited if Christo's employment is terminated by the company for cause or by him without good reason before the payment date.
• · Christo will continue to serve as Chief Accounting Officer while serving as Interim CFO.

29-05-2026

AVAX ONE TECHNOLOGY LTD. held its Annual Meeting of Shareholders on May 29, 2026, with 52.784% of outstanding shares voted. All five director nominees were elected, and shareholders ratified the appointment of CBIZ CPAs P.C. as auditor for FY2026. However, while the reverse stock split (ratio 1:2 to 1:12) and advisory say-on-pay proposal passed, the reverse split received notable opposition (1,786,289 votes against) and the say-on-pay vote saw 435,293 withhold votes, indicating some shareholder dissent.

• · Record date for voting was April 17, 2026.
• · Broker non-votes totaled 16,911,744 on director elections and the say-on-pay proposal.
• · Ratification of CBIZ CPAs P.C. passed with 47,725,597 for, 927,158 against, and 85,114 abstain.
• · Reverse split approval: 46,903,966 for, 1,786,289 against, 47,614 abstain.
• · Advisory say-on-pay: 31,341,982 for, 435,293 against, 48,850 abstain, plus 16,911,744 broker non-votes.
• · The filing was signed by Jolie Kahn as CEO, but the registrant name in the signature block is 'AGRIFORCE GROWING SYSTEMS, LTD.' (possible legacy name).

29-05-2026

Navient Corporation completed a public offering of $500,000,000 aggregate principal amount of 9.375% Senior Notes due 2031, issued under an Underwriting Agreement with BofA Securities, Barclays Capital, J.P. Morgan Securities, and RBC Capital Markets. The notes bear a 9.375% interest rate, mature in 2031, and were issued under a base indenture (2014) with a seventeenth supplemental indenture dated May 29, 2026.

• · The offering was made under Navient's shelf registration statement on Form S-3 (Registration No. 333-286944) filed May 2, 2025.
• · Underwriters have customary representations, warranties, and indemnification provisions.
• · The notes are governed by a base indenture dated July 18, 2014, supplemented by the seventeenth supplemental indenture dated May 29, 2026.
• · The notes trade on The Nasdaq Global Select Market under the symbol JSM.

29-05-2026

HealthLynked Corp filed Amendment No. 2 to its S-1 registration statement on May 29, 2026, detailing its executive team and board of directors. The filing introduces a largely experienced management team, including new CFO Jeremy Daniel (appointed Jan 2025) and COO Duncan McGillivray (appointed Dec 2025), along with several new directors. No financial performance data or offering details are included in this excerpt, limiting assessment of the company's operational trends.

• · The filing is Amendment No. 2 to Form S-1 (Registration No. 333-293324), filed on May 29, 2026.
• · Jeremy Daniel was appointed CFO effective January 15, 2025; Duncan McGillivray was appointed COO effective December 8, 2025.
• · Chris G. Pulos and Jason Bishara became directors in December 2025.
• · George O'Leary served as CFO from August 6, 2014 until April 4, 2024, and has been a director since August 6, 2014.
• · No financial results, revenue figures, or offering size/price are disclosed in this excerpt.

29-05-2026

Employers Holdings, Inc. held its 2026 annual meeting of stockholders on May 28, 2026, electing all eight director nominees, approving advisory say-on-pay compensation, and ratifying Ernst & Young LLP as independent auditor. All proposals passed with strong shareholder support, with director votes ranging from approximately 12.6 million to 13.0 million votes for, and say-on-pay receiving 12.84 million votes for vs. 0.18 million against.

• · Broker non-votes were 795,537 on all director elections and say-on-pay, but zero on auditor ratification
• · Auditor ratification received 13,563,407 votes for, 260,799 against, 19 abstentions
• · Say-on-pay votes: 12,842,180 for, 180,661 against, 5,847 abstentions
• · Highest director vote: Katherine H. Antonello (13,022,892 for); lowest vote for: John M. de Figueiredo (12,582,132 for)
• · Steven P. Sorenson had only 6,841 votes against, the lowest opposition among directors

29-05-2026

urban-gro, Inc. filed a definitive additional proxy statement (DEFA14A) on May 29, 2026, supplementing its proxy statement for the Special Meeting of Shareholders scheduled for June 3, 2026. The sole purpose of the supplement is to correct the number of outstanding shares of common stock entitled to vote, updating it to 1,404,499 as of the record date of May 6, 2026. This correction does not alter any other proxy materials or voting instructions; shareholders who already voted need not take further action.

• · The special meeting will be held on June 3, 2026.
• · Shareholders are allowed one vote per share of common stock.
• · Any previously requested proxy cards remain valid and unchanged.
• · Shareholders who have not yet voted are urged to vote using the methods described in the original proxy statement.

29-05-2026

SL Investment Fund II LLC filed an amendment (Form 10-Q/A) to its quarterly report for the period ended March 31, 2026, solely to include revised certifications from its CEO and CFO that were inadvertently omitted from the original filing. The amendment does not change any previously reported financial results or reflect events after the original filing date.

• · The amendment (Amendment No. 1) was filed on May 29, 2026, to correct certifications under Section 302 of the Sarbanes-Oxley Act.
• · Original Form 10-Q was filed on May 14, 2026.
• · No financial results were changed; the amendment only adds revised CEO and CFO certifications.
• · The company is an emerging growth company and has elected not to use the extended transition period for new financial accounting standards.
• · Commission file number is 814-01754.

29-05-2026

First Interstate BancSystem, Inc. filed a Certificate of Amendment to its Certificate of Incorporation, effective May 28, 2026, to change the standard for electing directors from plurality voting to majority voting, except in contested elections where plurality voting will still apply as set forth in the Bylaws. The amendment was approved by the Board on February 24, 2026, and subsequently ratified by shareholders at the 2026 Annual Meeting. No financial figures or period-over-period comparisons are included in this filing.

• · The amendment was adopted by the Board on February 24, 2026, and approved by shareholders at the 2026 Annual Meeting.
• · Majority voting applies to director elections except in contested elections, where plurality voting will be used as defined in the Bylaws.
• · Cumulative voting for directors is explicitly prohibited.
• · The amendment became effective upon filing with the Delaware Secretary of State on May 28, 2026.

29-05-2026

Kodiak AI, Inc. (formerly AACT) filed an S-1 registration statement detailing its business combination completed on September 24, 2025, which included a domestication from the Cayman Islands to Delaware, a merger with Legacy Kodiak, and concurrent financings. The company raised $145.0 million through a Series A Preferred Stock investment and $60.0 million through a PIPE, while also securing $43.9 million in Second Lien Loans. However, the filing also reveals that $10.0 million of the Exchanged SAFE Loan remains outstanding and not converted, and no amounts were drawn under the $20.0 million delayed draw facility, indicating potential liquidity constraints.

• · The exercise price of Private Placement Warrants and Public Warrants was adjusted to $9.28 on October 20, 2025.
• · Earn Out Securities are subject to three price thresholds: $18.00, $23.00, and $28.00 per share, with 25,000,000 securities vesting at each threshold.
• · The Earn Out Period ends on September 24, 2029, or upon a Change of Control.
• · 50% of SPAC Sponsor's Common Stock (SPAC Sponsor Earn Out Shares) are subject to vesting upon Triggering Event I.
• · One Preferred Investor's $50.0 million PIPE commitment was replaced by a Series A Preferred Investment.
• · $10.0 million of PIPE subscriptions were satisfied by non-redeemed AACT Class A Ordinary Shares.
• · The Exchanged SAFE Loan of $10.0 million remains outstanding and was not converted into Common Stock.
• · No amounts were drawn under the $20.0 million SPAC Sponsor Affiliate Delayed Draw Loans.

29-05-2026

Hertz Global Holdings held its 2026 Annual Meeting on May 28, 2026, where shareholders elected two director nominees—Lucy Clark Dougherty and Evangeline Vougessis—to the Board for terms ending in 2029. Shareholders also ratified Ernst & Young as the independent auditor for FY 2026 and approved, on an advisory basis, executive compensation. Notably, the two director nominees received strong majority support, but Evangeline Vougessis had a significantly higher number of withheld votes (25.4M) vs. Lucy Clark Dougherty (2.5M), and broker non-votes were material at ~35.9M for the director elections and the executive compensation vote.

• · Two director positions were up for election; terms until 2029.
• · Evangeline Vougessis received ~25.4M withheld votes (10.9% of votes cast) vs. Lucy Clark Dougherty's ~2.5M (1.1% withheld).
• · Broker non-votes on director elections and executive compensation were ~35.9M, representing a significant portion of total shares not voted on those items.
• · Auditor ratification was a non-broker-non-vote item and passed with ~266.2M For vs. 2.3M Against.
• · Advisory say-on-pay was approved with ~228.3M For vs. 3.9M Against, but broker non-votes were excluded, so only ~232.1M votes were cast on that matter.

29-05-2026

Amerant Bancorp Inc. appointed Adrian Rodriguez as Executive Vice President and Chief Operating Officer, effective May 26, 2026, after he served as Interim COO since November 10, 2025. The compensation terms for his new role have not yet been determined and will be disclosed in a future filing. No family relationships or reportable transactions exist between Mr. Rodriguez and the company's directors or officers.

• · Mr. Rodriguez previously served as Executive Vice President and Head of Loan Operations since 2022, overseeing loan and credit operations, legal documentation, servicing, loan accounting, and regulatory compliance.
• · From 2019 to 2022, he was Senior Vice President and Internal Controls Manager, managing SOX compliance and third-party vendor risk.
• · He earned a BBA in 2007 and an MBA in 2010, both from Florida International University.
• · No arrangements or understandings exist with any other persons regarding his appointment.

29-05-2026

Averin Capital Acquisition Corp. appointed Akiko Moni Miyashita, age 70, to its board of directors effective May 28, 2026. Ms. Miyashita brings over 25 years of experience in strategy, finance, and corporate development, with expertise in healthcare, life sciences, technology, and global markets. She has signed standard joinder agreements waiving certain redemption rights and agreeing to vote her shares in favor of an initial business combination, which is typical for a SPAC seeking a merger target.

• · Ms. Miyashita served on the board of Halozyme Therapeutics from May 2022 to May 2026.
• · She was Executive Vice President and Chief Strategy Officer of Valo Health from May 2019 to September 2024.
• · She served as a Senior Advisor at McKinsey & Company from October 2011 to September 2015 and as a Partner at Innosight LLC from August 2015 to August 2019.
• · From July 2003 through October 2011, she was Vice President of Corporate Development at IBM.
• · Ms. Miyashita signed a joinder to the Letter Agreement dated February 18, 2026, waiving certain redemption rights and agreeing to vote her shares in favor of an initial business combination.
• · She also signed a joinder to the Registration Rights Agreement dated February 18, 2026, granting her registration rights for any ordinary shares she owns.
• · No family relationships exist between Ms. Miyashita and any other directors or executive officers.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.